Hedge Fund - Tang Capital Management

Kalvista Pharmaceuticals Inc. (KALV) 

Holding History Records
No. Filing Period Value % of Portfolio Number of Shares Avg. Quarterly Share Price
1 2025 - Q4 (2025-12-31) $73,862,510 3.65% 4,573,530 $13.24
2 2025 - Q3 (2025-09-30) $61,409,100 2.36% 5,041,798 $13.82
3 2025 - Q2 (2025-06-30) $55,867,026 2.82% 4,941,798 $12.23
4 2025 - Q1 (2025-03-31) $57,028,349 3.15% 4,941,798 $10.21
5 2024 - Q4 (2024-12-31) $41,450,884 2.74% 4,893,847 $10.36
6 2024 - Q3 (2024-09-30) $50,043,514 3.57% 4,321,547 $12.58
7 2024 - Q2 (2024-06-30) $49,697,806 5.06% 4,218,829 $11.67
8 2024 - Q1 (2024-03-31) $48,926,592 5.09% 4,125,345 $13.33
9 2023 - Q4 (2023-12-31) $42,144,226 3.89% 3,440,345 $9.10
10 2023 - Q3 (2023-09-30) $33,130,522 4.67% 3,440,345 $10.22
11 2023 - Q2 (2023-06-30) $23,862,537 3.51% 2,651,393 $9.22
12 2023 - Q1 (2023-03-31) $20,839,949 3.1% 2,651,393 $7.46
13 2022 - Q4 (2022-12-31) $21,607,975 3.13% 3,196,446 $5.36
14 2022 - Q3 (2022-09-30) $26,118,000 3.2% 1,800,000 $13.98
15 2022 - Q2 (2022-06-30) $17,712,000 2.68% 1,800,000 $11.03
16 2022 - Q1 (2022-03-31) $9,555,000 1.91% 648,269 $14.37

The displayed share prices are average quarterly stock market prices.

The share numbers are adjusted according to following stock splits:

  1. 1.0000:14.0000 on 2016-11-22

  2. 1.0000:14.0000 on 2016-11-21